Co-Authors
                                
                                
                                    This is a "connection" page, showing publications co-authored by Kevin Bouiller and François Goehringer.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.115
         
        
        
     
 
    
        
        - 
            An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
            
            
                Score: 0.059
            
         
        
        - 
            Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? J Infect. 2020 Nov; 81(5):816-846.
            
            
                Score: 0.056